
CNC · NYSE
Centene is a managed-care company that provides healthcare coverage through government-sponsored and commercial programs. Its principal businesses include Medicaid, Medicare-related coverage, and individual and commercial marketplace plans, serving members who obtain insurance through public programs, employers, or exchanges. The supplied evidence does not provide a segment contribution split, member count, or operating scale by business. At the company level, Centene reported $174.6 billion of fiscal 2025 revenue, up from $145.5 billion in fiscal 2024, but swung to a $6.7 billion net loss from $3.3 billion of net income.
Centene gained $0.16, or 0.25%, from $63.91 to $64.07 over the stated week. The path was materially more volatile than the net result: the stock fell to $61.82 on July 29 and $60.84 on July 30 before recovering to $62.22 on July 31 and $63.76 on August 3, then edging higher on August 4. The supplied evidence identifies no company-specific earnings release, guidance change, contract, or management announcement behind those moves. Instead, investor attention appears to have been shaped by Zacks commentary labeling Centene a value stock and a July 30 Zacks Rank #1 momentum pick, although the evidence does not establish that either article drove trading.